Top Medical Searches

Roche to seize leap-frog opportunity in lung cancer

LONDON (Reuters) – After lagging rivals in cancer immunotherapies, Swiss drugmaker Roche hopes to leap-frog into the lead in the biggest market, tackling previously untreated lung cancer.

 Read more…

Be Sociable, Share!
December 7th, 2017 Posted in Drug
Copyright 2008 © Drugs and Diseases. Developed by Axilosoft
Home | About Us | Privacy Policy | Contact Us